Company intelligence / Profile preview
Metagenomi
Emeryville, California, United Statesmetagenomi.co ↗
- Ownership
- Public · MGX
- Employees
- ~202
- Development stage
- Preclinical
01
Overview
Metagenomi has a lead program for Hemophilia A (MGX-001) that demonstrated sustained FVIII activity in NHP studies for more than 16 months. The company has also achieved in vivo proof-of-concept in rodents for three secreted protein targets and four cardiometabolic programs in collaboration with Ionis, including 95% protein knockdown in spontaneous hypertensive rats.
- Therapeutic areas
- HematologyEndocrinologyRare DiseasesCardiovascular
- Modalities
- Gene editingBase editorsRNA-mediated integrationDNA-mediated integrationPrime editing systemsCRISPR-associated transposases (CAST)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Ionis PharmaceuticalsAffini-T TherapeuticsModerna (terminated May 2024)
04
Financials
- Market cap
- $43.7M
- Total revenue
- $-257K
- Enterprise value
- $-39.3M
Beyond the preview
Go deeper on Metagenomi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Metagenomi.